Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVernalis PLC Share News (VER)

  • There is currently no data for VER

TechMARK movers: Director buying at e2v

Mon, 08th Mar 2010 14:58
Shares in electronic components supplier e2v Technologies perked up following last Friday's announcement that its chairman had increased his stake in the company. This comes at a time when e2v has been hit by industrial strife at its Grenoble facility. It anticipates that this will reduce turnover by around £7m in the current quarter. That will significantly reduce group profitability.Chris Geoghegan acquired 123,512 shares at 40p each. He invested just short of £50,000. This takes his stake to 203,512 shares, equivalent to 0.1% of e2v. Net debt was £52.4m at the end of 2009, following the rights issue and placing at 70p a share that raised £55.8m gross just before the end of last year. The company is in the middle of a restructuring of the business in the UK as well as at Grenoble. There was a negative share price reaction to drug developer Vernalis buying back all the rights to royalties receivable from Menarini's sales of acute migraine treatment frovatriptan. Vernalis has paid Paul Capital Healthcare $32.57m (£21m) for these rights. PCH has also been granted 2.1 warrants over Vernalis shares. PCH paid €18.4m in April 2008 for a 90% interest in the royalties. Vernalis gets 25.25% of sales of frovatriptan in the EU and Central America. In 2009, sales were €32.4m. This will give Vernalis a sustainable income stream. FTSE TechMARK - RisersTrafficmaster (TFC) 33.00p +4.76%Alterian (ALN) 149.50p +4.55%Emblaze (BLZ) 45.50p +4.00%Telecity Group (TCY) 406.10p +2.94%Alphameric (ALM) 28.00p +2.75%Kewill (KWL) 105.00p +2.69%E2V Technologies (E2V) 39.50p +2.60%Puricore (PURI) 11.00p +2.33%Biocompatibles International (BII) 255.00p +2.00%Ark Therapeutics (AKT) 13.75p +1.85%FTSE TechMARK - FallersSkyepharma (SKP) 63.00p -5.97%Sepura (SEPU) 47.00p -5.05%Gresham Computing (GHT) 18.50p -3.90%Vernalis (VER) 72.00p -3.36%Morse (MOR) 37.50p -3.23%Axis-Shield (ASD) 377.00p -2.84%Phoenix IT Group (PNX) 280.00p -2.44%Oxford Biomedica (OXB) 11.00p -2.22%Torotrak (TRK) 24.00p -2.04%Renishaw (RSW) 607.00p -1.94%

Related News

Seneca Global Adds Aberdeen New Thai Director Gilding To Board
6 Mar 2020

Seneca Global Adds Aberdeen New Thai Director Gilding To Board

Seneca Global Adds Aberdeen New Thai Director Gilding To Board

Vernalis Shares Suspended From Trading On AIM Pending Announcement (ALLISS)
10 Oct 2018

Vernalis Shares Suspended From Trading On AIM Pending Announcement (ALLISS)

LONDON (Alliance News) - Shares in Vernalis PLC were temporarily suspended from trading on AIM on Wednesday as requested by the company pending an ann...

Ligand Acquisition Of Vernalis Gets Go-Ahead From Shareholders
2 Oct 2018

Ligand Acquisition Of Vernalis Gets Go-Ahead From Shareholders

LONDON (Alliance News) - Vernalis PLC on Tuesday said its acquisition by Ligand Holdings UK has been approved by shareholders.The pharmaceutical compa...

Vernalis PLC News

Seneca Global Adds Aberdeen New Thai Director Gilding To Board
6 Mar 2020

Seneca Global Adds Aberdeen New Thai Director Gilding To Board

Seneca Global Adds Aberdeen New Thai Director Gilding To Board

Vernalis Shares Suspended From Trading On AIM Pending Announcement (ALLISS)
10 Oct 2018

Vernalis Shares Suspended From Trading On AIM Pending Announcement (ALLISS)

LONDON (Alliance News) - Shares in Vernalis PLC were temporarily suspended from trading on AIM on Wednesday as requested by the company pending an ann...

Ligand Acquisition Of Vernalis Gets Go-Ahead From Shareholders
2 Oct 2018

Ligand Acquisition Of Vernalis Gets Go-Ahead From Shareholders

LONDON (Alliance News) - Vernalis PLC on Tuesday said its acquisition by Ligand Holdings UK has been approved by shareholders.The pharmaceutical compa...

UK Shareholder Meetings Calendar - Next 7 Days
25 Sep 2018

UK Shareholder Meetings Calendar - Next 7 Days

Wednesday 26 SeptemberIMIMobileHornbyNCC GroupPZ CussonsGateley 27

Vernalis Non-Exec Director Gilham Leaves Ahead Of Takeover
16 Aug 2018

Vernalis Non-Exec Director Gilham Leaves Ahead Of Takeover

LONDON (Alliance News) - Pharmaceutical firm Vernalis PLC on Thursday said Ian Gilham is leaving his role as a non-executive director.Chairman Peter F...

Ligand Pharma to buy Vernalis for just under £33m in cash
9 Aug 2018

Ligand Pharma to buy Vernalis for just under £33m in cash

(Sharecast News) - AIM-listed Vernalis has agreed to be bought by Ligand UK, a subsidiary of California-based Ligand Pharmaceuticals, for 6.2p per sha...

Ligand Holdings UK Agrees To Buy Vernalis For GBP32.7 Million
9 Aug 2018

Ligand Holdings UK Agrees To Buy Vernalis For GBP32.7 Million

LONDON (Alliance News) - Pharmaceutical company Vernalis PLC said Thursday that it reached an agreement to be taken over by Ligand Holdings UK Ltd.Lig...

WINNERS & LOSERS SUMMARY: Rolls Royce Flies High With Planned Job Cuts
14 Jun 2018

WINNERS & LOSERS SUMMARY: Rolls Royce Flies High With Planned Job Cuts

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Thursday.----------FTSE 100 - up 2....